BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 22727093)

  • 1. Antifungal activity of coronarin D against Candida albicans.
    Kaomongkolgit R; Jamdee K; Wongnoi S; Chimnoi N; Techasakul S
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Jul; 114(1):61-6. PubMed ID: 22727093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro antifungal sensitivity of fluconazole, clotrimazole and nystatin against vaginal candidiasis in females of childbearing age.
    Khan F; Baqai R
    J Ayub Med Coll Abbottabad; 2010; 22(4):197-200. PubMed ID: 22455297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungal activity of alpha-mangostin against Candida albicans.
    Kaomongkolgit R; Jamdee K; Chaisomboon N
    J Oral Sci; 2009 Sep; 51(3):401-6. PubMed ID: 19776506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro susceptibility of vaginal isolates of Candida vs clotrimazole and nystatin].
    Suárez VL; Fernández Andreu CM
    Rev Cubana Med Trop; 2003; 55(3):138-45. PubMed ID: 15849917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative action of 8 azole derivatives against Candida albicans: fungistatic action and cytologic study by scanning electron microscopy].
    Mallie M; Jouvert S; Bastide M; Montes B; Lebecq JC; Bastide JM
    Pathol Biol (Paris); 1988 May; 36(5):575-80. PubMed ID: 3043361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal activity of Morinda citrifolia fruit extract against Candida albicans.
    Jainkittivong A; Butsarakamruha T; Langlais RP
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Sep; 108(3):394-8. PubMed ID: 19716507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in situ antiyeast activity of Gracilaria changii methanol extract against Candida albicans.
    Sasidharan S; Darah I; Jain K
    Eur Rev Med Pharmacol Sci; 2011 Sep; 15(9):1020-6. PubMed ID: 22013724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of in vitro activity of carvacrol against Candida albicans strains.
    Vardar-Unlu G; Yağmuroğlu A; Unlu M
    Nat Prod Res; 2010 Jul; 24(12):1189-93. PubMed ID: 20582812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro synergic antifungal effect of MUC7 12-mer with histatin-5 12-mer or miconazole.
    Wei GX; Bobek LA
    J Antimicrob Chemother; 2004 May; 53(5):750-8. PubMed ID: 15073161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined effects of hyperbaric oxygen and antifungal agents on the growth of Candida albicans.
    Gudewicz TM; Mader JT; Davis CP
    Aviat Space Environ Med; 1987 Jul; 58(7):673-8. PubMed ID: 3304267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The mode of action of imidazole antimycotics: implications for sensitivity testing (author's transl)].
    Haller I
    Mykosen; 1979 Dec; 22(12):423-30. PubMed ID: 396473
    [No Abstract]   [Full Text] [Related]  

  • 12. Fungicidal effect of three new synthetic cationic peptides against Candida albicans.
    Nikawa H; Fukushima H; Makihira S; Hamada T; Samaranayake LP
    Oral Dis; 2004 Jul; 10(4):221-8. PubMed ID: 15196144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential fungicidal effect of voriconazole against Candida spp.
    Rubio MC; de Ocáriz IR; Gil J; Benito R; Rezusta A
    Int J Antimicrob Agents; 2005 Mar; 25(3):264-7. PubMed ID: 15737524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
    De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E
    J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifungal activity and mode of action of thymol and its synergism with nystatin against Candida species involved with infections in the oral cavity: an in vitro study.
    de Castro RD; de Souza TM; Bezerra LM; Ferreira GL; Costa EM; Cavalcanti AL
    BMC Complement Altern Med; 2015 Nov; 15():417. PubMed ID: 26601661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro comparative study of the fungistatic and fungicidal activity of sertaconazole and other antifungals against Candida albicans.
    Palacín C; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1992 May; 42(5A):711-4. PubMed ID: 1627188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of licorice compounds licochalcone A, glabridin and glycyrrhizic acid on growth and virulence properties of Candida albicans.
    Messier C; Grenier D
    Mycoses; 2011 Nov; 54(6):e801-6. PubMed ID: 21615543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifungal effect of high- and low-molecular-weight chitosan hydrochloride, carboxymethyl chitosan, chitosan oligosaccharide and N-acetyl-D-glucosamine against Candida albicans, Candida krusei and Candida glabrata.
    Seyfarth F; Schliemann S; Elsner P; Hipler UC
    Int J Pharm; 2008 Apr; 353(1-2):139-48. PubMed ID: 18164151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent antifungal activity of extracts and pure compound isolated from pomegranate peels and synergism with fluconazole against Candida albicans.
    Endo EH; Cortez DA; Ueda-Nakamura T; Nakamura CV; Dias Filho BP
    Res Microbiol; 2010 Sep; 161(7):534-40. PubMed ID: 20541606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Investigation of the activity of the preparation cerbiden against Candida spp].
    Hladun NP; Bondarenko AS; Nahorna SS; Smyrnova OV
    Mikrobiol Z; 2002; 64(6):57-61. PubMed ID: 12664551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.